Keywords
Medication compliance
Influencing factors
Submitted : 2026-01-26
Accepted : 2026-02-10
Published : 2026-02-25
Abstract
Coronary heart disease (CHD) is one of the chronic cardiovascular diseases with a high disability rate, high morbidity, and high mortality worldwide. Long-term drug management is of great significance to control the disease, reduce the recurrence rate of cardiovascular events, and improve the quality of life of patients. However, the drug compliance of patients with CHD is generally not high, and the current situation is worrying. Studies have shown that there are differences in drug compliance among patients in different regions and different age groups. This study reviewed the concept of coronary heart disease, the concept and connotation of medication compliance, the analysis of medication compliance status of patients with coronary heart disease and the analysis of influencing factors, providing basis for clinical medical staff to quickly screen out high-risk patients with low compliance, and to carry out early and accurate intervention, in order to effectively improve patient medication compliance, improve long-term prognosis, reduce readmission rate and medical burden.
References
You L, Wu Y, 2022, Internal Medicine Nursing, 7th Edition, People’s Medical Publishing House, Beijing.
Giroli MG, Werba JP, Ris é P, et al., 2021, Effects of Mediterranean Diet or Low-Fat Diet on Blood Fatty Acids in Patients with Coronary Heart Disease. A Randomized Intervention Study, 13(7): 2389.
Compilation Group of China Cardiovascular Health and Disease Report, 2022, Summary of China Cardiovascular Health and Disease Report 2021. China Circulation Journal, 37(6): 553–578.
National Center for Cardiovascular Disease, China Cardiovascular Health and Disease Report Compilation Group, Hu S, 2024, China Cardiovascular Health and Disease Report 2023 Summary. China Circulation Journal, 39(7): 625–660.
Chen M, Lin J, Chen Q, et al., 2023, The Therapeutic Effect of Therapeutic Communication Model and Nursing Model Combined with Atorvastatin on Patients with Coronary Atherosclerotic Heart Disease and Its Impact on Negative Emotions. Jilin Medicine, 44(9): 2656–2658.
Qian Y, Luo P, 2019, Medication Compliance Issues in Patients with Chronic Diseases and the Application of Information Technology in Compliance Management. Contemporary Medicine, 25(4): 180–183．
Hou J, Zhao H, Miao H, et al., 2025, Scope Review of Medication Compliance Assessment Tools for Patients with Chronic Diseases. Journal of Nursing Continuing Education, 40(12): 1326–1332.
Pietrzykowski Ł, Michalski P, Kosobucka A, et al., 2020, Medication Compliance and Its Determinants in Patients After Myocardial Infarction. Sci Rep, 10(1): 12028.
Wei P, Guo X, Yin J, et al., 2021, Investigation and Study on Disease Perception and Medication Compliance in Patients with Coronary Heart Disease. Shanghai Nursing, 21(05): 46–48.
Zhang MJ, Feng F, Zhang J, 2025, Study on Drug Literacy and Drug Compliance in Elderly Patients with Coronary Heart Disease. China Modern Doctors, 63(1): 43–46, 62.
Bosselmann L, Fangauf SV, Herbeck Belnap B, et al., 2020, Blended Collaborative Care in the Secondary Prevention of Coronary Heart Disease Improves Risk Factor Control: Results of a Randomised Feasibility Study. Eur J Cardiovasc Nurs, 19(2): 134–141.
Yu M, Wang L, Guan L, et al., 2022, Knowledge, Attitudes, and Barriers Related to Medication Compliance of Older Patients with Coronary Heart Disease in China. Geriatr Nurs, 43: 235–241.
Feng N, Zhang Y, Duan X, et al., 2023, Survey on Secondary Prevention Medication Use and Compliance in Patients with Coronary Heart Disease. South China Preventive Medicine, 49(3): 297–300.
Liu X, Deng Y, Wang Q, 2025, Study on the Correlation between Self-Perceived Burden and Secondary Prevention Medication Compliance in Patients with Coronary Heart Disease. Health Professions Education, 43(09): 146–150.
Gong C, Yuan B, Hua Z, 2022, Analysis of Current Status and Influencing Factors of Secondary Prevention Medication Compliance in Patients with Coronary Heart Disease. South China Preventive Medicine, 48(10): 1260–1263.
Zhang R, Cheng G, Tang W, et al., 2024, Analysis of Secondary Prevention Medication Compliance and Influencing Factors in Patients with Coronary Heart Disease in Daxing Area of Beijing. South China Preventive Medicine, 50(02): 168–171.
Deng B, Gao R, 2019, Investigation on Compliance with Medication Orders and Analysis of Influencing Factors in 1682 Elderly Patients with Coronary Heart Disease After Discharge. Evaluation and Analysis of Drug Use in Chinese Hospitals, 19(8): 997–999, 1004.
Li Y, Zhang Y, Zeng L, et al., 2020, Survey on the Perceptions of Community General Practitioners in 11 Cities in China on the Use of Antiplatelet Drugs to Prevent Cardiovascular Disease. Chinese Journal of General Practitioners, 19(11): 1014–1019.
Morisky DE, Ang A, Krousel-Wood M, et al., 2008, Predictive Validity of a Medication Compliance Measure in an Outpatient Setting. Clin Hypertens (Greenwich), 10(5): 348–354.
Weng Y, Zhao Y, Liu W, et al., 2018, Research on the Reliability, Validity and Application of the Chinese Version of the 8-Item Morisky Medication Compliance Scale in Patients with Type 2 Diabetes. Chinese Journal of Clinicians (Electronic Version), 12(8): 445–450.